Imaging3 files for Chapter 11; Given Imaging seeks PillCam approval in Japan;

 @FierceMedDev: Japan's Olympus (makes med equipment/cameras) may be very close to getting a huge investment from Sony. WSJ reports. More | Follow @FierceMedDev

 @MarkHFierce: The U.S.'s othopedic soft tissue device market should grow to $2 billion by 2016, Millennium Research Group believes. More | Follow @MarkHFierce

 @DamianFierce: Torax Medical snagged $30M in VC funding to market its anti-acid reflux device. Story | Follow @DamianFierce

> Imaging3, a maker of 3D medical diagnostic imaging devices, is filing for Chapter 11 bankruptcy. News

> Healthsense, a startup developing wireless remote monitoring devices for seniors, pulled in a $7 million Series D round. Report

> Given Imaging ($GIVN) will pursue Japanese regulatory approval for its PillCam Colon 2, a video capsule that patients swallow in order to capture endoscopic images. Release

> As the medical device world prepares for January's 2.3% excise tax on U.S. sales, many companies are scrambling to figure out how the charge will affect their products. Item

> Illumina ($ILMN) is buying the U.K.'s BlueGnome, maker of in vitro diagnostics, for an undisclosed sum. More

> IntelliRad Control is developing a device to reduce the amount of radiation patients are exposed to in diagnostic procedures, and the company raised $5.3 million venture financing. Article

> Thermo Fisher Scientific ($TMO) has opened an R&D center in Vilnius, Lithuania, looking to develop new diagnostic assays and expand its sales in Eastern Europe. Release

> Utah's Concept to Company is offering $45,000 to medical device entrepreneurs with fresh ideas through its medical innovation contest. Story

Biotech News

 @FierceBiotech: fuels biotech's hunt for flu therapies. Story | Follow @FierceBiotech

 @JohnCFierce: The Fierce 15: An appetite for risk is healthy in drug development. Report | Follow @JohnCFierce

 @RyanMFierce: 10 pharma giants form nonprofit to gang up on common R&D foes. More | Follow @RyanMFierce

> Baxter and Onconova ink $500M-plus licensing pact for PhIII cancer drug. News

> After FDA blessings for diet drugs, spotlight shines on biotechs' pioneering obesity meds. More

> Wellington Partners rounds up $91M for new European life sciences fund. Article

Pharma News

 @FiercePharma: Working Mother's Top 100 employers list includes 10 drugmakers. Discrimination lawsuits (for some) notwithstanding. More | Follow @FiercePharma

> Lundbeck to stop making cancer drug. Story

> Lawyers seek to force J&J chief onto the stand in Risperdal case. News

> Pfizer faces class action claiming Wyeth misled investors on Pristiq. More

Drug Delivery News

> Fast migraine treatment battles sickness, too. Story

> BDSI's addiction oral patch approaches the market. Article

> Origami DNA may take twist out of doxorubicin delivery. News

> Ultrasound gets drugs right under the skin. More

Biomarkers News

> Genetic biomarkers and the frets of the 'worried well'. More

> Gene mutations point to personalized therapy in lung cancer. Story

> Breath biomarkers could breathe life into lung cancer tests. Article

> BRCA mutations may pinpoint response to Abbott's veliparib. News